Ads
related to: lung cancer, study- EGFRm mNSCLC Progression
What's Next When Patients Progress
On EGFR-TKIs? Visit Site For Info.
- A New Line Of Thinking
For When EGFR-TKI Resistance Leads
To Progression in mNSCLC. Read More
- Addressing The Unmet Need
Learn About The Unmet Need For
Options That Can Improve Outcomes
- View Possible Approaches
See The Need For Additional Options
In EGFRm mNSCLC. Learn More.
- EGFRm mNSCLC Progression
- 262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
Search results
Court orders Army to review claim that soldier died due to malpractice
Army Times via Yahoo News· 24 hours agoAnd the odds for these kinds of lawsuits are extremely poor. Master Sgt. Richard Stayskal, the...
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials
MedPage Today· 6 days agoTTHealthWatch is a weekly podcast from Texas Tech. This week's topics include early diagnosis and...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 1 day agoA recent study in the New England Journal of Medicine grabbed the attention of the medical community...
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and...
FOX 59 Indianapolis· 7 days agoLunit will present detailed findings on several innovative studies, including the identification of HER2 ultra-low expression in breast cancer using AI-based quantification ...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 2 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
The growing promise of cancer vaccines
Cosmos· 5 days agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet ...
Obesity and Cancer: Untangling a Complex Web
Medscape· 3 days agoThe incidence of many of these cancers has been rising in recent years, particularly among younger people — a trend that sits in contrast with the...
From Robust Response to Rapid Resistance
MedPage Today· 7 days agoThe cancer treatment landscape dramatically changed since the first approval of an immune checkpoint inhibitor (ICI), ipilimumab, a CTLA-4 inhibitor, in...
All Over the Map? Mechanisms of ICI Acquired Resistance in NSCLC
MedPage Today· 7 days ago"Resistance is futile." What's less debatable, though, is that patients with non-small cell lung ...
How Long Do Short People Live?
Verywell Health via Yahoo News· 2 days agoThe study's researchers suspect people with longer legs and tall people are subject to greater leg stasis (blood collection in the lower legs) because of...
